HealthRecordCommunity
FHIRHL7🌏 International🏛 Cambridge Prisms / i-HD Task ForceEnriched

i-HD Task Force Accelerates eSource Scale-Up in Oncology Clinical Trials: Addressing Data Flow and Quality

加速肿瘤临床试验eSource规模化应用:i-HD任务组倡议与实施路线图 - 生物通

October 15, 2025Cambridge Prisms / i-HD Task Force

Summary

Cambridge Prisms reports on the i-HD Task Force's initiative to scale up eSource use in oncology clinical trials. This effort aims to solve challenges related to EHR-to-EDC data migration, KPI tracking, and overall data collection efficiency.

Details

This article details the efforts of the i-HD Task Force, involving Cambridge Prisms, to accelerate the scale-up of eSource (electronic source) in oncology clinical trials. The initiative addresses key challenges inherent in traditional data transfer processes from EHRs to EDCs, particularly concerning standardized interoperability and KPI management. The core focus is on optimizing the data flow and improving data quality by utilizing advanced technologies like AI and ML. Through pilot implementations at facilities such as City of Hope, the project aims to streamline workflows and ensure compliance with stringent data standards like ALCOA+. Key impacts include reducing manual workload (estimated 25%-40% reduction) and enhancing overall data collection efficiency. The initiative emphasizes moving beyond simple system integration towards a comprehensive solution that guarantees high-quality, standardized data capture. This focus on robust interoperability between EHR and EDC systems is highly relevant to the Japanese healthcare IT sector, which also prioritizes seamless, standards-based data exchange.

📰
Read Original Article
ebiotrade.com

Original content copyright by respective publishers